Methods and compositions for the treatment of MHC-associated conditions
US7208154B2 · kind B2 · utility
5Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 2004 |
| Grant date | Apr 24, 2007 |
| Priority date | — |
| Expiry date | May 13, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and compositions for counteracting and reversing disease-causing signaling defects in disorders with underlying signal transduction aberrations, including but not limited to rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.